CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Hyperthermia for Cancer Treatment

This policy governs coverage of local and whole-body hyperthermia used as a cancer treatment for BlueCHiP for Medicare and Commercial products, specifying when local hyperthermia is considered medically necessary and when whole-body or standalone hyperthermia is not covered.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyHyperthermia for Cancer Treatment

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateAug 1, 2008

Next Review DateN/A

Key ActionVerify member-specific benefits and Evidence of Coverage prior to providing hyperthermia services.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Local hyperthermia coveredIndication where coverage may be provided

Whole-body not coveredModality not covered

CPT codes listedCoding

Not applicablePrior auth

Coverage Criteria for Hyperthermia

Medically necessary use

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyHyperthermia for Cancer Treatment

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateAug 1, 2008

Next Review DateN/A

Key ActionVerify member-specific benefits and Evidence of Coverage prior to providing hyperthermia services.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Not medically necessary / Not covered

Not covered / Not medically necessary: Local hyperthermia is not covered/not medically necessary when used alone or in combination with chemotherapy; whole-body hyperthermia therapy is not covered/not medically necessary due to insufficient peer-reviewed evidence.

Triggers non-coverage for BlueCHiP for Medicare and not medically necessary for Commercial products as stated in policy.

Local hyperthermia therapy is covered when ALL of the following are met: it is used in combination with radiation therapy for the treatment of patients with primary or metastatic cutaneous or subcutaneous superficial tumors. The policy specifies that local hyperthermia used alone or in combination with chemotherapy is not covered/not medically necessary for BlueCHiP for Medicare and is not medically necessary for Commercial products.

Whole-body hyperthermia therapy is not covered for BlueCHiP for Medicare and is not medically necessary for Commercial products due to insufficient peer-reviewed evidence supporting the procedure.

Whole-body hyperthermia therapy involves systemic elevation of core body temperature and is explicitly considered not medically necessary in this policy because there are inadequate data to permit scientific conclusions regarding its use as an adjunct to radiation or chemotherapy.

The policy further states that local hyperthermia used alone or in combination with chemotherapy is not covered/not medically necessary; coverage is limited to local hyperthermia only when combined with radiation therapy for primary or metastatic cutaneous or subcutaneous superficial tumors.

Coding and Procedure Codes

Covered CPT Codes for local hyperthermia if medically necessaryCPTCovered

77600	Hyperthermia, externally generated; superficial (eg, to a depth of 4 cm or less) heating.
77610	Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators.
77615	Hyperthermia generated by interstitial probe(s); more than 5 interstitial applicators.

Not covered / not medically necessary CPT CodesCPTNot Covered

77620	Hyperthermia generated by intracavitary probe(s).
77605	Hyperthermia, externally generated; deep (ie, to depths greater than 4 cm) heating.

Whole-body hyperthermia coding guidanceCPT

Unlisted

No specific CPT procedure code for whole-body hyperthermia; report use with an unlisted code.

Provider Actions, Prior Authorization, and Denial Triggers

Prior Authorization

Prior authorization is not required for this therapy. Providers should verify member-specific benefits and eligibility prior to treatment.

Prior authorization: Not applicable
Verify benefits per the member's Evidence of Coverage or Subscriber Agreement

Documentation Required

Benefit Verification and Documentation

Confirm member coverage, applicable radiation therapy benefits, and whether hyperthermia services are a covered benefit for the member's contract before scheduling or billing.

Refer to the member's Evidence of Coverage or Subscriber Agreement for benefit details
Contact Provider Services / Provider Call Center for member-specific eligibility and benefit verification

Denial Risk

Coverage Exclusions / Denial Triggers

Coverage exclusions that may trigger claim denial or determination of not medically necessary: document and verify before providing services.

Whole‑body hyperthermia: Not covered for BlueCHiP for Medicare and considered not medically necessary for Commercial products
Local hyperthermia used alone or in combination with chemotherapy: Not covered for BlueCHiP for Medicare and considered not medically necessary for Commercial products
Local hyperthermia may be considered medically necessary only when used in combination with radiation therapy for primary or metastatic cutaneous or subcutaneous superficial tumors — otherwise expect denial

Documentation Required

Provider Responsibilities and Documentation

Providers must obtain and retain documentation supporting medical necessity when billing for local hyperthermia in combination with radiation therapy; if services are determined not medically necessary or are non‑covered, members must be informed and provide written agreement before being balance‑billed.

Maintain documentation of diagnosis, treatment rationale, and that local hyperthermia is being provided in combination with radiation therapy when indicated
Do not bill members for services determined to be not medically necessary unless the member was informed and provided written agreement in advance per participation agreement
Benefits and eligibility determinations are governed by the member's subscriber agreement/certificate and employer agreement; these documents supersede this policy

Background

Hyperthermia is a cancer treatment that exposes tissue to elevated temperatures to damage and kill cancer cells. It can be delivered as local hyperthermia (targeting superficial or subcutaneous tumors by external or interstitial methods) or as whole-body (systemic) hyperthermia (raising core temperature under general anesthesia or deep sedation).

Local hyperthermia elevates temperature of a tumor while sparing surrounding normal tissue and is described in this policy as an adjunct to radiation therapy for superficial cutaneous or subcutaneous tumors. Whole-body hyperthermia is performed with monitored warming (policy text describes raising core temperatures up to approximately 108°F with subsequent cooling and prolonged observation) and is not supported by sufficient peer-reviewed evidence for coverage.

Definitions

Local hyperthermia (definition)

DefinitionTechniques that elevate the temperature of superficial or subcutaneous tumors while sparing surrounding normal tissue; can be delivered by external or interstitial modalities.

Typical applicationUsed as an adjunct to radiation therapy for primary or metastatic cutaneous or subcutaneous superficial tumors when medically necessary.

Delivery methodsExternal heating devices (superficial) or interstitial probes (placed into tissue).

Coverage noteConsidered medically necessary only when used in combination with radiation therapy; not medically necessary when used alone or with chemotherapy.

Whole-body hyperthermia (definition)

DefinitionSystemic elevation of body temperature achieved under anesthesia or deep sedation; described in policy as raising core temperature to approximately 108°F with monitored cooling and recovery.

Typical procedure detailsPatient placed under general anesthesia or deep sedation; body warmed (eg, heated blankets) to ~108°F, maintained for a period (described in source as about 4 hours) with close monitoring and subsequent cooling and observation.

Safety/monitoringRequires continuous monitoring of vital functions during heating and for an extended recovery/observation period afterward; may require anesthesia or deep sedation.

Coverage stanceWhole-body hyperthermia therapy is considered not medically necessary due to insufficient evidence.